Share on StockTwits

Advanced Medical Solutions Group plc (LON:AMS)‘s stock had its “hold” rating restated by Canaccord Genuity in a research note issued on Thursday. They currently have a GBX 101 ($1.72) target price on the stock. Canaccord Genuity’s price objective would indicate a potential downside of 8.11% from the stock’s previous close.

A number of other analysts have also recently weighed in on AMS. Analysts at Investec reiterated an “add” rating on shares of Advanced Medical Solutions Group plc in a research note on Thursday. They now have a GBX 129 ($2.20) price target on the stock. Separately, analysts at N+1 Singer reiterated a “hold” rating on shares of Advanced Medical Solutions Group plc in a research note on Thursday. They now have a GBX 103 ($1.75) price target on the stock. Finally, analysts at N+1 Singer reiterated a “hold” rating on shares of Advanced Medical Solutions Group plc in a research note on Thursday, May 29th. They now have a GBX 103 ($1.75) price target on the stock. Six investment analysts have rated the stock with a hold rating, The stock currently has a consensus rating of “Hold” and a consensus target price of GBX 111.67 ($1.90).

Advanced Medical Solutions Group plc (LON:AMS) opened at 110.00 on Thursday. Advanced Medical Solutions Group plc has a one year low of GBX 72.00 and a one year high of GBX 132.622. The stock has a 50-day moving average of GBX 116.5 and a 200-day moving average of GBX 116.6.

Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of novel high performance polymers, both natural and synthetic, for use in advanced woundcare dressings and of medical adhesives for closing and sealing tissue.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.